{"id":"W4389243136","doi":"10.1016/j.eururo.2023.11.015","title":"Reply to Lin Ding, Bin Yang, and Xudong Yao’s Letter to the Editor re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108","year":2023,"lang":"en","type":"letter","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme; AstraZeneca","keywords":"Medicine; Abiraterone; Olaparib; Placebo; Internal medicine; Prostate cancer; Cancer; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004830457,0.0009590426,0.002273103,0.001037849,0.002683973,0.002983584,0.002099529,0.03286688,0.005964715],"category_scores_gemma":[0.03090539,0.0009594812,0.001397973,0.0009875731,0.001925596,0.003232505,0.001174362,0.03796099,0.00881355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00335803,"about_ca_system_score_gemma":0.003569379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004502669,"about_ca_topic_score_gemma":0.005925969,"domain_scores_codex":[0.9972497,0.0008267232,0.0004903001,0.0003897606,0.0007382167,0.0003052651],"domain_scores_gemma":[0.9895722,0.005852504,0.0007680377,0.0002578873,0.002312268,0.001237085],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006522453,0.00001603113,0.0002246242,0.00005171606,0.00001344768,0.0004129417,0.0000469285,0.00002317553,0.00006777221,0.0003257981,0.9955329,0.00321945],"study_design_scores_gemma":[0.0002908154,0.0001458248,0.001667432,0.0004650837,0.00007895557,0.002548822,0.0004056499,0.0004650427,0.0003845575,0.005059903,0.9883699,0.0001179364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0001827536,0.001464169,0.00006639356,0.9665756,0.03097703,0.00001155996,0.00009111859,0.00003544203,0.0005959162],"genre_scores_gemma":[0.00151637,0.0009514932,0.0001223558,0.9554881,0.0389607,0.00003818893,0.000037769,0.00002719605,0.002857778],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.03286688,"threshold_uncertainty_score":0.02554625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1495319722172449,"score_gpt":0.3815436196601418,"score_spread":0.2320116474428969,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}